Evidence map›Paper›PMID 29529199›Full record

ArticleHuman molecular genetics2018

Superoxide dismutating molecules rescue the toxic effects of PINK1 and parkin loss.

Alice Biosa, Alvaro Sanchez-Martinez, Roberta Filograna, Ana Terriente-Felix, Sarah M Alam, Mariano Beltramini, Luigi Bubacco, Marco Bisaglia, Alexander J Whitworth

Open access · hybridAbstract read
In one paragraph

Article in Human molecular genetics, 2018. The graph could read no effect estimate from its abstract, so it casts no vote on the map. Cited by 17 papers.

0numbers the graph read from it
0cells of the map it votes in
17citing papers in PubMed
3.1field-weighted citation impact, top 9% of its field
1 · What the graph read from it

What it found

Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.

The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.

2 · The registry

The trial behind it

Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.

Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.

3 · Its place in the literature

Who cites it

17 citing papers in PubMed, 30 citations in OpenAlex.

  1. Review
  2. Article
  3. Article
  4. Article
  5. Review
  6. Article
  7. Article
  8. Article
  9. Review
  10. Article
  11. Article
  12. Article
  13. Antioxidant Therapy in Parkinson's Disease: Insights fromAntioxidants (Basel, Switzerland) · 2020
    Review
  14. Review
  15. Review
  16. Review
  17. Article
4 · The record

Corrections and comments

PubMed lists nothing against this paper. Absence here is not a guarantee, only a check that was made.

5 · Who and what money

Authors and funding

9 authors at 2 institutions in 2 countries.

Alice BiosaMolecular Physiology and Biophysics Unit, Department of Biology, University of Padova, 35131 Padova, Italy.
Alvaro Sanchez-MartinezMRC Mitochondrial Biology Unit, University of Cambridge, Cambridge Biomedical Campus, Cambridge CB2 0XY, UK.
Roberta FilogranaMolecular Physiology and Biophysics Unit, Department of Biology, University of Padova, 35131 Padova, Italy.
Ana Terriente-FelixMRC Mitochondrial Biology Unit, University of Cambridge, Cambridge Biomedical Campus, Cambridge CB2 0XY, UK.
Sarah M AlamMRC Mitochondrial Biology Unit, University of Cambridge, Cambridge Biomedical Campus, Cambridge CB2 0XY, UK.
Mariano BeltraminiMolecular Physiology and Biophysics Unit, Department of Biology, University of Padova, 35131 Padova, Italy.
Luigi BubaccoMolecular Physiology and Biophysics Unit, Department of Biology, University of Padova, 35131 Padova, Italy.
Marco BisagliaMolecular Physiology and Biophysics Unit, Department of Biology, University of Padova, 35131 Padova, Italy.
Alexander J WhitworthMRC Mitochondrial Biology Unit, University of Cambridge, Cambridge Biomedical Campus, Cambridge CB2 0XY, UK.
University of Padua · ITUniversity of Cambridge · GB

Funding

European Research Council 309742Medical Research Council MC_UP_1501/1Medical Research Council MC_UU_00015/6Medical Research Council MC_UU_00015/7
6 · The paper itself

Abstract

Reactive oxygen species exert important functions in regulating several cellular signalling pathways. However, an excessive accumulation of reactive oxygen species can perturb the redox homeostasis leading to oxidative stress, a condition which has been associated to many neurodegenerative disorders. Accordingly, alterations in the redox state of cells and mitochondrial homeostasis are established hallmarks in both familial and sporadic Parkinson's disease cases. PINK1 and Parkin are two genes which account for a large fraction of autosomal recessive early-onset forms of Parkinson's disease and are now firmly associated to both mitochondria and redox homeostasis. In this study we explored the hypothesis that superoxide anions participate in the generation of the Parkin and PINK1 associated phenotypic effect by testing the capacity of endogenous and exogenous superoxide dismutating molecules to rescue the toxic effects induced by loss of PINK1 or Parkin, in both cellular and fly models. Our results demonstrate the positive effect of an increased level of superoxide dismutase proteins on the pathological phenotypes, both in vitro and in vivo. A more pronounced effectiveness for mitochondrial SOD2 activity points to the superoxide radicals generated in the mitochondrial matrix as the prime suspect in the definition of the observed phenotypes. Moreover, we also demonstrate the efficacy of a SOD-mimetic compound, M40403, to partially ameliorate PINK1/Parkin phenotypes in vitro and in vivo. These results support the further exploration of SOD-mimetic compounds as a therapeutic strategy against Parkinson's disease.

Indexed as

Blotting, WesternHEK293 CellsHeLa CellsHumansManganeseOrganometallic CompoundsOxidative StressParkinson DiseaseProtein KinasesPTEN-Induced Putative KinaseReactive Oxygen SpeciesSuperoxide DismutaseSuperoxide Dismutase-1Superoxide Dismutase 2Ubiquitin-Protein Ligasesimisopasem manganeseManganeseOrganometallic Compoundsparkin proteinProtein KinasesPTEN-Induced Putative KinaseReactive Oxygen SpeciesSOD1 protein, humanSuperoxide DismutaseSuperoxide Dismutase-1Superoxide Dismutase 2Ubiquitin-Protein Ligases

Identifiers

PMID29529199
PMCPMC5905640
OpenAlexW2791277299

What OpenQuestion holds

Textmetadata
LicenceCC BY
Read underepoch 390

Registered trials

None linked

Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the OpenQuestion graph.